BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11794064)

  • 41. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis.
    Heidenreich A; Thüer D; Polyakov S
    Eur Urol; 2008 Feb; 53(2):260-72. PubMed ID: 18045770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. French AFU Cancer Committee Guidelines - Update 2022-2024: testicular germ cell cancer.
    Murez T; Fléchon A; Branger N; Savoie PH; Rocher L; Camparo P; Neuville P; Ferretti L; Van Hove A; Roupret M
    Prog Urol; 2022 Nov; 32(15):1066-1101. PubMed ID: 36400478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Surgical aspects in the treatment of patients with testicular cancer.
    Richie JP
    Hematol Oncol Clin North Am; 1991 Dec; 5(6):1127-42. PubMed ID: 1663937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Observations after orchiectomy in clinical stage I nonseminomatous germ cell tumors of the testis.
    Kuo JY; Chin T; Hsieh YL; Lin AT; Chang YH; Wei C; Chen KK; Chang LS
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):356-61. PubMed ID: 10389293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delayed orchiectomy at postchemotherapy retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic pattern consistent with testicular primary: assessment of pathologic findings.
    Brown JA; Bihrle R; Foster RS
    Urology; 2008 May; 71(5):911-4. PubMed ID: 18342916
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary chemotherapy in patients with nonseminomatous germ cell tumors of the testis and biological disease only after orchiectomy.
    Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
    J Urol; 1996 Apr; 155(4):1296-8. PubMed ID: 8632558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of extensiveness of testicular germinoma on the choice of a treatment regimen].
    Gorelov AI; Bogdanova EO; Komiakova BK
    Vopr Onkol; 2003; 49(4):455-8. PubMed ID: 14569936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nonseminomatous germ cell tumors of the testis: current concepts and controversies.
    Sheinfeld J
    Urology; 1994 Jul; 44(1):2-14. PubMed ID: 7518979
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of patients with retroperitoneal metastases of nonseminoma tumors of the testis].
    Matveev BP; Figurin KM
    Vopr Onkol; 1988; 34(12):1493-7. PubMed ID: 2464238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of chemotherapy and surgery in the treatment of retroperitoneal metastases in advanced nonseminomatous testis cancer.
    Vugrin D; Whitmore WF
    Cancer; 1985 May; 55(9):1874-8. PubMed ID: 4038913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Burned-out tumor and carcinoma-in-situ of the testis mimicking an extragonadal germ cell tumor: a case report].
    Kayada K; Yamaguchi O; Irisawa C; Muraki O
    Hinyokika Kiyo; 1996 Aug; 42(8):613-6. PubMed ID: 8889574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrated approach to the management of patients with advanced germ cell tumors of the testis.
    Ravi R; Rao RR; Shanta V
    J Surg Oncol; 1994 Jan; 55(1):47-51. PubMed ID: 8289453
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection.
    Hermans BP; Sweeney CJ; Foster RS; Einhorn LE; Donohue JP
    J Urol; 2000 Jun; 163(6):1721-4. PubMed ID: 10799168
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical studies of testicular tumor. II. Analysis of 30 patients with nonseminomatous testicular tumor].
    Tsukamoto T; Kumamoto Y; Ohmura K; Tsunekawa T; Yamazaki K
    Hinyokika Kiyo; 1986 Jul; 32(7):999-1011. PubMed ID: 2430437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of retroperitoneal lymph node dissection in the management of testicular cancer.
    Stephenson AJ; Sheinfeld J
    Urol Oncol; 2004; 22(3):225-33; discussion 234-5. PubMed ID: 15271322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distribution of nodal metastases after chemotherapy in nonseminomatous testis cancer: a possible indication for limited dissection.
    Ehrlich Y; Yossepowitch O; Kedar D; Baniel J
    BJU Int; 2006 Jun; 97(6):1221-4. PubMed ID: 16686715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advanced non-seminomatous germ cell cancer of the testis with brain metastases: feasibility of additional brain irradiation and whole body hyperthermia plus chemotherapy.
    Feyerabend T; Wiedemann GJ; Steeves R
    Oncol Rep; 2001; 8(2):219-23. PubMed ID: 11182030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Germ cell testicular tumours with lung metastases: chemotherapy and surgical treatment.
    Cărsky S; Ondrus D; Schnorrer M; Májek M
    Int Urol Nephrol; 1992; 24(3):305-11. PubMed ID: 1328104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Secondary acute monocytic leukemia occurring during the treatment of a testicular germ cell tumor. A case report and review of the literature.
    Nonomura N; Murosaki N; Kojima Y; Kondoh N; Seguchi T; Takeda Y; Oji Y; Ogawa H; Sugiyama H; Miki T; Okuyama A
    Urol Int; 1997; 58(4):239-42. PubMed ID: 9253126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.